Urotoxic ifosfamide metabolites

Urotoxic ifosfamide metabolites, primarily acrolein and chloroacetaldehyde, are reactive chemical species generated during the hepatic metabolism of the alkylating chemotherapy agent ifosfamide (StatPearls, 2023). Ifosfamide is activated by cytochrome P450 enzymes, specifically CYP3A4 and CYP2B6, to produce the active ifosfamide mustard and the byproduct acrolein (PubMed, 15163115). Acrolein is a highly reactive unsaturated aldehyde that concentrates in the bladder, where it causes direct oxidative damage and alkylation of the urothelium, leading to hemorrhagic cystitis (PubChem, CID 7847). Chloroacetaldehyde, another metabolite formed via side-chain dechloroethylation, is implicated in ifosfamide-induced nephrotoxicity and neurotoxicity (PubMed, 15163115). While these metabolites are not traditional biological targets like receptors or enzymes, they are the pharmacological targets of the uroprotective agent Mesna (sodium 2-mercaptoethanesulfonate) (FDA Label, Mesna). Mesna provides a thiol group that chemically reacts with acrolein in the urinary tract to form a stable, non-toxic thioether, thereby preventing bladder injury (StatPearls, 2023).

Other names

AcroleinChloroacetaldehyde2-propenal2-chloroacetaldehydeIfosfamide metabolites

Mesna acts as a regional detoxifying agent by chemically reacting with the electrophilic double bond of acrolein via Michael addition in the urinary tract, forming a stable, non-toxic thioether conjugate.